NOV Q3: Solid Revenue and Margin Growth Reinforce Buy Thesis

What happened

NOV reported third-quarter 2026 revenue of $2.23 billion, up 4% sequentially and 2% year-over-year, with net income of $90 million and adjusted EBITDA of $281 million (12.6% margin). Both operating segments expanded margins, indicating successful execution of higher-margin backlog. This follows a period where 2Q25 book-to-bill was 66% and aftermarket was soft, so the sequential improvement is a positive signal. However, the earnings release did not provide updated backlog or order intake figures, leaving uncertainty about the durability of the improvement. The results align with the master report's thesis of a mix shift to offshore/international and margin resilience, but key risk factors remain.

Implication

The solid Q3 performance supports the view that NOV can convert its high-quality backlog into improving profitability. However, the lack of detailed order and backlog data means the market may focus on the next quarter's book-to-bill to gauge momentum. Continued execution on offshore and international projects should sustain margin improvement, while aftermarket recovery could add upside. Risks from oil price softness and potential project delays remain, but the current trajectory suggests the master report's positive stance is intact. Investors should monitor upcoming disclosures on backlog, orders, and segment margins for validation.

Thesis delta

The Q3 results do not alter the core thesis; they provide evidence of margin expansion and revenue growth consistent with the master report's expectations. The BUY stance remains, but the lack of order intake data means the key watch item of book-to-bill improvement is still unconfirmed. No shift in stance is warranted at this time.